AHA is pleased to support the Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2023.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
The AHA voices support legislation, the Resident Physician Shortage Reduction Act of 2023 (H.R. 2389).
The Save Rural Hospitals Act would establish a national minimum rate of 0.85 for the AWI reimbursement rate, resulting in an infusion of new federal dollars to rural hospitals at this critical time.
AHA comments on three topics that were discussed during the March 2023 Medicare Payment Advisory Commission public meeting: the hospital wage index, alignment of payment rates across ambulatory settings and Medicare Part B drug payments.
The AHA is pleased to support the Rural Hospital Support Act (S. 1110).
FAH, AHA Oppose Legislation Allowing Unfettered Growth of Self-referral to Physician-owned Hospitals
New Analysis Shows Physician-owned Hospitals Cherry-pick Patients, Provide Less Uncompensated and Emergency Care.
AHA's feedback on a Drug Enforcement Administration proposed rule for the telemedicine prescribing of controlled substances when there has not been a prior in-person medical evaluation.
AHA provides feedback on the Drug Enforcement Administration’s (DEA’s) proposed rule for expansion of induction of buprenorphine via telemedicine encounter.
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.